menu
    • menu

    Company profile for Hesperos

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The mission of Hesperos, Inc. is to accelerate drug discovery through the use of scalable, multi-organ, microphysiological systems (also known as: Human-on-a-Chip®) that provide analytic services for the pharmaceutical, cosmetic, and food industries. These services allow research teams to determine how the human body will respond when new drug compounds are introduced – something that previously required costly animal testi...
    The mission of Hesperos, Inc. is to accelerate drug discovery through the use of scalable, multi-organ, microphysiological systems (also known as: Human-on-a-Chip®) that provide analytic services for the pharmaceutical, cosmetic, and food industries. These services allow research teams to determine how the human body will respond when new drug compounds are introduced – something that previously required costly animal testing and human trials to determine. Hesperos systems will reduce the cost of drug development and bring better therapies to patients faster than ever, while eliminating the need for animal testing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HesperosUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12501 Research Pkwy, Suite 100 Orlando, FL 32826
    Telephone
    Telephone
    (407) 900-5915
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hesperosinc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hesperos-inc./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/HesperosInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hesperos, Bayer Develop First Human-On-A-Chip Model
    Hesperos, Bayer Develop First Human-On-A-Chip Model

    08 Oct 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/rd/hesperos-and-bayer-consumer-health-develop-frst-human-on-a-chip-model-of-stress-induced-cognitive-dysfunction-17965

    INDPHARMAPOST
    08 Oct 2025
    Share Share
    Hesperos, Bayer Develop First Human-On-A-Chip Model
    Hesperos, Bayer Develop First Human-On-A-Chip Model

    07 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251007268083/en/Hesperos-and-Bayer-Consumer-Health-Develop-First-Human-on-a-Chip-Model-of-Stress-Induced-Cognitive-Dysfunction

    BUSINESSWIRE
    07 Oct 2025
    Share Share
    Hesperos Builds 1st Digital Twin Using Organ-on-Chip
    Hesperos Builds 1st Digital Twin Using Organ-on-Chip

    22 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250722297482/en/Hesperos-Demonstrates-First-Digital-Twin-of-Human-Disease-Using-Organ-on-a-Chip-Platform

    BUSINESSWIRE
    22 Jul 2025
    Share Share
    Psilera Partners with Hesperos to advance PSIL-006 for Dementia
    Psilera Partners with Hesperos to advance PSIL-006 for Dementia

    09 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psilera-collaborates-with-drug-development-leader-hesperos-to-advance-preclinical-modeling-of-psil-006-for-frontotemporal-dementia-302475744.html

    PR NEWSWIRE
    09 Jun 2025
    Share Share
    Hesperos Wins ACC.25 Pitch Competition, FDA Plans Animal Testing
    Hesperos Wins ACC.25 Pitch Competition, FDA Plans Animal Testing

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250430854275/en/Hesperos-Wins-ACC.25-Pitch-Competition-as-FDA-Unveils-Plan-to-Move-Beyond-Animal-Testing

    BUSINESSWIRE
    01 May 2025
    Share Share
    Hesperos & UCF Develop Human-on-a-Chip® For Opioid Crisis
    Hesperos & UCF Develop Human-on-a-Chip® For Opioid Crisis

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250109726985/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search